Kits Eyecare Ltd. (TSX:KITS)

Kits Eyecare Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	27.39	29.82	19.27	16.04	18.79	20.51
Trading Asset Securities	-	3.86	-	-	-	-
Cash & Short-Term Investments	27.39	33.67	19.27	16.04	18.79	20.51
Cash Growth	51.17%	74.74%	20.14%	-14.64%	-8.36%	788.43%
Accounts Receivable	2.75	2.22	2.2	1.69	0.85	0.44
Other Receivables	0.01	0.15	0.33	0.12	0.07	0.42
Receivables	2.76	2.36	2.53	1.8	0.92	0.86
Inventory	25.46	23.67	22.49	15.41	16.41	13.49
Prepaid Expenses	1.28	0.98	0.79	0.73	0.88	0.86
Total Current Assets	56.89	60.69	45.08	33.98	37	35.71
Property, Plant & Equipment	9.82	9.12	10.86	8.65	10.04	10.93
Goodwill	40.68	39.23	41.19	37.86	38.77	36.29
Other Intangible Assets	1.14	1.13	1.15	1.47	2.94	4.46
Long-Term Deferred Tax Assets	1.08	2.65	4.76	5.68	5.12	3.55
Long-Term Deferred Charges	0.1	0.13	-	-	-	-
Total Assets	109.71	112.96	103.02	87.64	93.87	90.94

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	23.49	22.22	21.83	12.89	14.47	8.36
Accrued Expenses	-	4.28	3.42	3.07	2.34	1.94
Current Portion of Long-Term Debt	-	10.28	5.38	3.03	3.1	3.05
Current Portion of Leases	0.89	0.83	0.84	0.69	0.62	0.55
Current Income Taxes Payable	0.44	0.43	0.45	0.41	0.42	0.4
Current Unearned Revenue	7.38	7.35	6.83	4.43	3.49	2.53
Total Current Liabilities	32.2	45.37	38.75	24.52	24.44	16.82
Long-Term Debt	-	-	1.78	6.69	10.04	13.04
Long-Term Leases	4.26	4.72	4.6	4.98	5.67	6.3
Other Long-Term Liabilities	0.45	0.55	-	-	-	-
Total Liabilities	36.91	50.65	45.13	36.2	40.16	36.16

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	86.35	81.77	78.16	77.39	76.99	76.59
Additional Paid-In Capital	3.47	2.45	3.13	3.04	2.86	1.94
Retained Earnings	-18.26	-21.69	-24.8	-27.91	-25.7	-21.15
Comprehensive Income & Other	1.24	-0.22	1.4	-1.07	-0.44	-2.6
Total Common Equity	72.8	62.31	57.89	51.45	53.71	54.79
Shareholders' Equity	72.8	62.31	57.89	51.45	53.71	54.79
Total Liabilities & Equity	109.71	112.96	103.02	87.64	93.87	90.94

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	5.15	15.82	12.6	15.39	19.44	22.94
Net Cash (Debt)	22.23	17.85	6.67	0.65	-0.65	-2.44
Net Cash Growth	113.95%	167.61%	932.66%	-	-	-
Net Cash Per Share	0.65	0.53	0.20	0.02	-0.02	-0.08
Filing Date Shares Outstanding	34.01	33.99	31.98	31.44	31.32	31.16
Total Common Shares Outstanding	33.94	32.27	31.56	31.44	31.32	31.16
Working Capital	24.7	15.31	6.32	9.46	12.56	18.89
Book Value Per Share	2.15	1.93	1.83	1.64	1.72	1.76
Tangible Book Value	30.98	21.95	15.56	12.12	12	14.04
Tangible Book Value Per Share	0.91	0.68	0.49	0.39	0.38	0.45
Buildings	-	0.43	0.31	0.17	0.05	0.05
Machinery	-	7.27	7.7	4.14	3.81	3.33
Leasehold Improvements	-	0.91	0.95	0.87	0.87	0.8

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error